Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 9, 2004, Pages 859-863

  Gleeson, F ^a   Ryan, E ^a   Barrett, S ^a   Crowe, J ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Biochemical screening; Hereditary haemochromatosis (HH); Identified C282Y HH homozygotes; Penetrance; Serum ferritin (SF); Transferrin saturation (TS )

Indexed keywords

FERRITIN; LIVER ENZYME; TRANSFERRIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DISORDERS OF METAL METABOLISM; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC SCREENING; HEMOCHROMATOSIS; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRELAND; IRON BLOOD LEVEL; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX RATIO;

ADOLESCENT; ADULT; AGED; FEMALE; FERRITINS; GENETIC SCREENING; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRELAND; IRON OVERLOAD; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PENETRANCE; PHLEBOTOMY; TRANSFERRIN;

EID: 4444332039     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200409000-00008     Document Type: Article

References (19)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.
2. Beutler E, Gelbart T, West C. Mutation analysis in hereditary haemochromatosis. Blood Cells Mol Dis 1996; 22:187-194.
3. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, Penetrance of 845G-A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211-218.
4. Olynyx JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341:718-724.
5. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001; 114:474-484.
6. Ryan E, O'Keane C, Crowe J. Haemochromatosis in Ireland and HFE. Blood Cells Mol Dis 1998; 24:428-432.
7. Byrnes V, Ryan E, Mayne P, Crowe J, Neonatal screening for the HFE mutations in the Irish population. Gut 1999; 1:527A.
8. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34:275-278.
9. Willis G, Wimperis JZ, Lonsdale R. Incidence of liver disease in people with HFE mutations. Gut 2000; 46:401-404.
10. Burke W, Thomson E, Khoury MJ. Hereditary hemochromatosis gene discovery and its implications for population based screening. J Am Med Assoc 1998; 280:172-178.
11. Jeffrey GP, Chakrabarti S, Hegele RA. Polymorphism in intron 4 of HFE may cause over estimation of C282Y prevalence in haemochromatosis. J Pathol Bacteriol 1962; 84:53-64.
12. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early haemochromatosis and determination of the clinical iron level associated with fibrosis. J Hepatol 1986; 6:24-29.
13. Ryan E, Byrnes V, Coughlan B, Barrett S, O'Keane J, Crowe J. Under-diagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut 2002; 51:108-112.
14. McClune Ca, Al-Jader LN, May A, Hayes SL, Jackson HA, Worwood M. Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet 2002; 111:538-543.
15. Beutler E. Rebuttal to Ajioka and Kushner. Blood 2003; 101:3354-3357.
16. Ajioka R, Kushner J. Clinical consequences of iron overload in hemochromatosis homozygotes. Blood 2003; 101:3351-3354.
17. Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998; 43:830-836.
18. Bulaj ZJ, Ajioka RS, Philips JD, LaSalle BA, Jorde LB, Griffen LM, et al. Disease related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000; 343:1529-1535.
19. Asberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelonning K, Fjosne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36:1108-1115.